Skip to main content

Advertisement

Log in

Botulinum toxin improves reduced dorsiflexion after Achilles tendon surgery

  • Ankle
  • Published:
Knee Surgery, Sports Traumatology, Arthroscopy Aims and scope

Abstract

Generally, outcome after surgical repair of complete Achilles tendon rupture is good. However, some patients have ongoing problems with dorsiflexion of the ankle joint. We report on eight patients, who did not achieve heel contact because of reduced ankle dorsiflexion 5 months after surgical repair of complete Achilles tendon rupture. All patients received at least three cycles of injections with 200–300 units of Botulinum toxin A (BOTOX®) into the gastrocnemius and soleus muscle. Weakening of the triceps surae by Botulinum toxin allowed patients to perform the required exercises and to tolerate casting at night. Thus, all patients were able to tolerate plantigrade foot position 9 months after beginning of Botulinum toxin treatment. At final follow-up after 2 years, pain had significantly improved, and a mean dorsiflexion of 21° was reached. In conclusion, treatment of the calf muscles with BOTOX® is a safe and effective method to improve restricted dorsiflexion in patients after Achilles tendon repair.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Alfredson H, Pietilä T, Jonsson P, Lornetzon R (1998) Heavy-load eccentric calf muscle training for the treatment of chronic Achilles tendinosis. Am J Sports Med 26:360–366

    CAS  PubMed  Google Scholar 

  2. Bhidayasiri R, Truong DD (2005) The expanding use of botulinum toxin. J Neurol Sci 235:1–9

    Article  CAS  PubMed  Google Scholar 

  3. Cook JL, Khan KM, Purdam C (2002) Achilles tendinopathy. Man Ther 7:121–130

    Article  CAS  PubMed  Google Scholar 

  4. DiStefano VJ, Nixon JE (1973) Rupturs of the Achilles tendon. J Sports Med 1:34–37

    Article  CAS  PubMed  Google Scholar 

  5. Fröberg A, Komi P, Ishikawa M, Movin T, Arndt A (2009) Force in the Achilles tendon during walking with ankle foot orthosis. Am J Sports Med 37:1200–1209

    Article  PubMed  Google Scholar 

  6. Kirazli Y, On AY, Kismali B, Aksit R (1998) Comparison of phenol block and botulinus toxin type A in the treatment of spastic foot after stroke. J Phys Med Rehab 77:510–515

    Article  CAS  Google Scholar 

  7. Kubat WD, Rekant M (2008) Botulinum use as an adjunctive in a patient with multiple flexor tendon ruptures. Hand (NY) 3:237–239

    Google Scholar 

  8. Lynch RM (2004) Achilles tendon rupture: surgical versus non-surgical treatment. Accid Emerg Nurs 12:149–158

    Article  PubMed  Google Scholar 

  9. Mancini F, Sandrini G, Moglia A, Nappi G, Paccheti C (2005) A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (BOTOX) for the treatment of spastic foot. Neurol Sci 26:26–31

    Article  CAS  PubMed  Google Scholar 

  10. Placzek R, Söhling M, Gessler M, Jerosch J (2004) Botulinum toxin in orthopaedic pain therapy. Schmerz 18:498–505

    Article  CAS  PubMed  Google Scholar 

  11. Reiter F, Danni M, Lagalla G, Ceravolo G, Provinciali L (1998) Low-dose botulinum toxin with ankle taping for the treatment of spastic equinovarus foot after stroke. Arch Phys Med Rehabil 79:532–535

    Article  CAS  PubMed  Google Scholar 

  12. Richardson D, Sheean G, Werring D, Desai M, Edwards S, Greenwood R, Thompson A (2000) Evaluating the role of botulinum toxin in the management of focal hypertonia in adults. J Neurol Neurosurg Psychiatry 69:499–506

    Article  CAS  PubMed  Google Scholar 

  13. Wissel J, Ward AB, Erztgaard P, Bensmail D, Hecht MJ, Lejeune TM, Schnider P (2009) European consensus table on the use of botulinum toxin type A in adult spasticity. J Rehabil Med 41:13–25

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

There was no funding or grant for the project provided from any source. Dr. Iris Reuter, Dr. Olaf Lorbach, Dr. Sabine Mehnert, Professor M. Kaps and Dr. Martin Engelhardt did not receive any financial benefits related to the cases reported. Dr. Martin Engelhardt, Dr. Olaf Lorbach and Professor Dr. Manfred Kaps have never received any grants from PharmAllergan or any other Botulinum toxin producing company. Dr. Iris Reuter has received educational grants from PharmAllergan, Ipsen and Merz in the past for projects not related to the case reports. Dr. Sabine Mehnert has received educational grants from PharmAllergan, Ipsen and Merz in the past for projects not related to the case reports. The case reports have not been presented at a conference or reported elsewhere.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Iris Reuter.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reuter, I., Lorbach, O., Mehnert, S. et al. Botulinum toxin improves reduced dorsiflexion after Achilles tendon surgery. Knee Surg Sports Traumatol Arthrosc 18, 265–268 (2010). https://doi.org/10.1007/s00167-009-0948-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00167-009-0948-0

Keywords

Navigation